Maternal <i>Tmprss6</i> is required for hepcidin suppression and fetal health

K Katherine L. Fielding (1Infection and Global Health Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia) C Cavan Bennett (1Walter and Eliza Hall Institute of Medical Research, Infection and Global Health, Parkville, Australia) A Anne Pettikiriarachchi N Naomi Jones (1Infection and Global Health Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia) R Rebecca Harding (1Infection and Global Health Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia) A Alistair R. D. McLean (1Infection and Global Health Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia) L Louise Randall (1Infection and Global Health Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia) U Ute Schaeper (4Drug Discovery Department, Silence Therapeutics GmbH, Berlin, Germany) A Alberto Martinez (5Department of Clinical Science, Silence Therapeutics PLC, Berlin, Germany) R Ricardo Ataide (1Walter and Eliza Hall Institute of Medical Research, Parkville, Australia) S Sant-Rayn Pasricha

Abstract

Abstract The antenatal role of the hepcidin-regulating protease Tmprss6 has never been elucidated because knockout dams are infertile. Using an in vivo knockdown approach, we confirm Tmprsss6 is critical for hepcidin suppression in pregnancy, and Tmprss6 inhibition drives deleterious fetal outcomes.

Article Details

Journal Blood
Volume / Issue Vol. 145, Issue 25
Published June 19, 2025
Pages 3056-3059
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (11)

K

Katherine L. Fielding

1Infection and Global Health Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia

C

Cavan Bennett

1Walter and Eliza Hall Institute of Medical Research, Infection and Global Health, Parkville, Australia

A

Anne Pettikiriarachchi

N

Naomi Jones

1Infection and Global Health Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia

R

Rebecca Harding

1Infection and Global Health Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia

A

Alistair R. D. McLean

1Infection and Global Health Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia

L

Louise Randall

1Infection and Global Health Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia

U

Ute Schaeper

4Drug Discovery Department, Silence Therapeutics GmbH, Berlin, Germany

A

Alberto Martinez

5Department of Clinical Science, Silence Therapeutics PLC, Berlin, Germany

R

Ricardo Ataide

1Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

S

Sant-Rayn Pasricha